Seeking Alpha

TEVA
Teva Pharmaceutical Industries Limited

5/26/2012, 3:15 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
TEVA Market Currents more »
  • Friday 2:53 PM Despite the recent pullback ahead of management's tempered guidance expectations yesterday, Teva (TEVA -0.2%) shares should still be avoided, says Piper Jaffray. The firm sees limited visibility for the company's generics businesses and lowers its price target to $44 from $45.
    2 Comments
    [Healthcare]
  • Thursday 9:05 AM More on Teva (TEVA) 2012 guidance: The EPS of forecast of $5.30-$5.40 is below prior guidance of $5.48-$5.68; revenue prediction of $20B-$21B is below $22B prior. Teva's Europe outlook has been affected by over $1B. If there are businesses that don't fit, "we'll be looking to divest," says CEO Jeremy Levin.
    2 Comments
    [Earnings, Healthcare]
  • Thursday 8:58 AM Teva (TEVA) provides 2012 guidance on a conference call to investors, saying it expects EPS of $5.30-$5.40 vs. consensus of $5.59. It forecasts net revenue of $20B-$21B vs. 21.27B. Breakdown: U.S. $10.5B, Europe $5.8B, ROW $4.2B, Copaxone $3.8B. Shares +1.4% premarket. (PR)
    2 Comments
    [Earnings, Healthcare]
TEVA in Focus more »
TEVA News more »
TEVA Instablog posts more »
  • K202 Weekly Review
    Wed, May 23 • John Lounsbury • Comment!
  • 15 Most Oversold Nasdaq 100 Stocks
    Mon, May 21 • TomAspray • Comment!
  • My Long-Term, Enhanced Investing-For-Income Strategy Discussion And Concentrator Blog
    Sun, May 6 • K202 • 17 Comments
  • Q1 2012 Biotech Chronicles: Avanir Pharmaceuticals
    Mon, Apr 2 • Kinetic Investments • 1 Comment
  • The Best Yielding Stock Buys Of Thomas S. Gayner (Markel Asset Management)
    Thu, Mar 8 • Dividend Sheet • Comment!
Write a post on TEVA
TEVA StockTalks
TEVA vs. ETF Alternatives
Company Description

Teva Pharmaceutical Industries Limited (“Teva”) is a global pharmaceutical company that develops, produces and markets generic drugs in all major therapeutic categories. We are the leading generic drug company in the world – with the leading position in the U.S. (in terms of both value and... More

Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: Israel